Cost-effectiveness analysis of pharmacogenomics (PGx)-based warfarin, apixaban, and rivaroxaban versus standard warfarin for the management of atrial fibrillation …

A Hafeez, LE Cipriano, RB Kim, GS Zaric… - …, 2024 - Springer
Objective To assess the cost-effectiveness of pharmacogenomics (PGx)-based warfarin (ie,
warfarin dosing following genetic testing), apixaban, and rivaroxaban oral anticoagulation …
被引用次数：2 相关文章

Cost-Effectiveness Analysis of Pharmacogenomics (PGx)-Based Warfarin, Apixaban, and Rivaroxaban Versus Standard Warfarin for the Management of Atrial …

A Hafeez, LE Cipriano, RB Kim… - …, 2024 - pubmed.ncbi.nlm.nih.gov
Objective To assess the cost-effectiveness of pharmacogenomics (PGx)-based warfarin (ie,
warfarin dosing following genetic testing), apixaban, and rivaroxaban oral anticoagulation …

Cost-Effectiveness Analysis of Pharmacogenomics (PGx)-Based Warfarin, Apixaban, and Rivaroxaban Versus Standard Warfarin for the Management of Atrial …

A Hafeez, LE Cipriano, RB Kim, GS Zaric… - …, 2024 - ideas.repec.org
Objective To assess the cost-effectiveness of pharmacogenomics (PGx)-based warfarin (ie,
warfarin dosing following genetic testing), apixaban, and rivaroxaban oral anticoagulation …

Cost-Effectiveness Analysis of Pharmacogenomics (PGx)-Based Warfarin, Apixaban, and Rivaroxaban Versus Standard Warfarin for the Management of Atrial …

A Hafeez, LE Cipriano, RB Kim, GS Zaric… - …, 2023 - europepmc.org
Objective To assess the cost-effectiveness of pharmacogenomics (PGx)-based warfarin (ie,
warfarin dosing following genetic testing), apixaban, and rivaroxaban oral anticoagulation …

Cost-Effectiveness Analysis of Pharmacogenomics (PGx)-Based Warfarin, Apixaban, and Rivaroxaban Versus Standard Warfarin for the Management of Atrial …

A Hafeez, LE Cipriano, RB Kim, GS Zaric… - …, 2024 - econpapers.repec.org
Objective To assess the cost-effectiveness of pharmacogenomics (PGx)-based warfarin (ie,
warfarin dosing following genetic testing), apixaban, and rivaroxaban oral anticoagulation …